- NCIt
- C4929
Loading cancer entity…
Loading cancer entity…
Clinical trials
15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07685938 | Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease | recruiting | Phase 2 | 60 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07338006 | Chest Wall Reconstruction Cohort | recruiting | N/A | 50 | University of Health Sciences LahoreOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT07018960 | "Multicenter Registry for Chest Wall Reconstruction Using Custom Dynamic Prostheses (PRODIPET)"(PRODIPET) | recruiting | N/A | 60 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07040527 |
Data updated 12 days agoSource updated Sep 17, 2026source: clinicaltrials
| Comparative Study on Medical Artificial Intelligence Algorithm Assisted and Conventional Imaging Examination Methods |
| not yet recruiting |
| — |
| 100 |
| Shanghai Jiao Tong University Affiliated Sixth People's HospitalOTHER |
| 0 |
| Jun 27, 2025 |
| clinicaltrials |
| NCT06994533 | Comparative Study on Different Bone Reconstruction After Chest Wall Tumor Resection | not yet recruiting | N/A | 50 | Shanghai Jiao Tong University Affiliated Sixth People's HospitalOTHER | 0 | May 29, 2025 | clinicaltrials |
| NCT06978075 | Artificial Intelligence Combined With 3D-Preformed Chest Wall Defection Reconstruction System in Chest Wall Tumor Surgery(AICW3DPCWDRS) | not yet recruiting | N/A | 50 | Wu WeimingOTHER | 0 | May 18, 2025 | clinicaltrials |
| NCT06977022 | Clinical Trial on the Efficacy and Safety of Biodegradable 3D-Printed Implants in Chest Wall Reconstruction Surgery | not yet recruiting | N/A | 20 | Tang-Du HospitalOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT03971045 | Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer(PERICLES) | recruiting | Phase 2 | 46 | European Institute of OncologyOTHER | 1 | Nov 19, 2024 | clinicaltrials |